ElectroCore INC
32
2
2
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
34.4%
11 terminated/withdrawn out of 32 trials
63.3%
-23.2% vs industry average
0%
0 trials in Phase 3/4
100%
19 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
Role: collaborator
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
Role: collaborator
Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.
Role: collaborator
Non-invasive Vagus Nerve Stimulation in Acute Ischemic Stroke
Role: collaborator
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
Role: collaborator
Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study
Role: collaborator
Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders
Role: collaborator
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
Role: collaborator
Treatment of Complications to Diabetic Autonomic Neuropathy With Vagus Nerve Stimulation
Role: collaborator
Neuromodulation in Patients With Painful Chronic Pancreatitis
Role: collaborator
Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study
Role: collaborator
Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury
Role: collaborator
Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines
Role: lead
Study of Gammacore Sapphire for the Acute and Preventive Treatment of Post-Traumatic Headache (GAP-PTH)
Role: collaborator
Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache
Role: lead
A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine
Role: lead
RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks
Role: lead
A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL)
Role: lead
Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy
Role: lead
Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations
Role: lead